Mannitol Drip (FDL)

Description

Indications

Mannitol Drip (FDL) is primarily indicated in conditions like Bladder irrigation, Cerebral oedema, Diuresis, Edematous states, Oliguria, Poisoning, Raised intracranial pressure, Raised iop, Renal insufficiency, Reperfusion injury, Sodium depletion, Termination of pregnancy

Side Effects

The severe or irreversible adverse effects of Mannitol Drip (FDL), which give rise to further complications include Dehydration, Hyponatremia, Oedema, Skin necrosis, Hyponatremia, Inflammation.,Mannitol Drip (FDL) produces potentially life-threatening effects which include Pulmonary edema, Convulsions, Hypertension, Hypotension, Anaphylaxis, Fluid & electrolyte imbalance, Water intoxication, which are responsible for the discontinuation of Mannitol Drip (FDL) therapy., The signs and symptoms that are produced after the acute overdosage of Mannitol Drip (FDL) include Coma, Confusion. Letharav. Stupor. Severe hyponatremia. The symptomatic adverse reactions produced by Mannitol Drip (FDL) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Thirst, Headache, Nausea, vomiting, Fever, Tachycardia, Blurred vision, Chills, Thrombophlebitis, Hypokalemia, Chest pain, Xerostomia, Urinary RetentionX, Urinary retention, dizziness.

Contraindication

Mannitol Drip (FDL) is contraindicated in conditions like Acidosis, Congestive heart failure,Pulmonary edema,Intracranial hemorrhage, Dehydration, Inadequate urine flow.

Warning 

Before rapid administration of Mannitol Drip (FDL) carefully evaluate patients cardiovascular status because sudden expansion of extracellular fluid lead to congestive heart failure (CHF). The diuretic response following 15-20% of Mannitol Drip (FDL) may further aggravate pre-existing hemoconcentration. Mannitol Drip (FDL) should not be administered untill the patient renal function and urine flow have been determined to be adequate using a test dose. The drug should be administered to the pregnant mother only when the potential benefits to the mother outweigh the potential risks to the fetus.